Correction to: Repurposing doxycycline as an adjunct to sitagliptin in type 2 diabetes mellitus: a randomized controlled study on glycemic, inflammatory, and cardiometabolic outcomes.

El-Khateeb E, Khrieba MO, Badawoud AM, Morsy AA, El-Hanafy AA, Hamza E, Habba E, El-Hanafy DA, Eltantawy N, Al-Dhelaan RA, Radwan KH, El-Sayed AA, Eladaroussay MM, Rizk KAK, Ebrahim MHE, Abd Elhameed AG, Erfan IA, Elkhodary NM, Elshorbagi N, Sami HM, Dewidar SA, Mahdy MA, Zakaria H

Open source

DOI: 10.1007/s00210-026-05640-y
Published: 2026 Sep
Container: Naunyn-Schmiedeberg's archives of pharmacology
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s00210-026-05640-y,
  title = {Correction to: Repurposing doxycycline as an adjunct to sitagliptin in type 2 diabetes mellitus: a randomized controlled study on glycemic, inflammatory, and cardiometabolic outcomes.},
  author = {El-Khateeb E and Khrieba MO and Badawoud AM and Morsy AA and El-Hanafy AA and Hamza E and Habba E and El-Hanafy DA and Eltantawy N and Al-Dhelaan RA and Radwan KH and El-Sayed AA and Eladaroussay MM and Rizk KAK and Ebrahim MHE and Abd Elhameed AG and Erfan IA and Elkhodary NM and Elshorbagi N and Sami HM and Dewidar SA and Mahdy MA and Zakaria H},
  year = {2026},
  journal = {Naunyn-Schmiedeberg's archives of pharmacology},
  doi = {10.1007/s00210-026-05640-y},
  url = {https://doi.org/10.1007/s00210-026-05640-y}
}

RIS

TY  - JOUR
TI  - Correction to: Repurposing doxycycline as an adjunct to sitagliptin in type 2 diabetes mellitus: a randomized controlled study on glycemic, inflammatory, and cardiometabolic outcomes.
AU  - El-Khateeb E
AU  - Khrieba MO
AU  - Badawoud AM
AU  - Morsy AA
AU  - El-Hanafy AA
AU  - Hamza E
AU  - Habba E
AU  - El-Hanafy DA
AU  - Eltantawy N
AU  - Al-Dhelaan RA
AU  - Radwan KH
AU  - El-Sayed AA
AU  - Eladaroussay MM
AU  - Rizk KAK
AU  - Ebrahim MHE
AU  - Abd Elhameed AG
AU  - Erfan IA
AU  - Elkhodary NM
AU  - Elshorbagi N
AU  - Sami HM
AU  - Dewidar SA
AU  - Mahdy MA
AU  - Zakaria H
PY  - 2026
JO  - Naunyn-Schmiedeberg's archives of pharmacology
DO  - 10.1007/s00210-026-05640-y
UR  - https://doi.org/10.1007/s00210-026-05640-y
ER  -

APA

E, E., MO, K., AM, B., AA, M., AA, E., E, H., E, H., DA, E., N, E., RA, A., KH, R., AA, E., MM, E., KAK, R., MHE, E., AG, A. E., IA, E., NM, E., N, E., HM, S., SA, D., MA, M., & H, Z. (2026). Correction to: Repurposing doxycycline as an adjunct to sitagliptin in type 2 diabetes mellitus: a randomized controlled study on glycemic, inflammatory, and cardiometabolic outcomes.. Naunyn-Schmiedeberg's archives of pharmacology. https://doi.org/10.1007/s00210-026-05640-y

Source records

pubmed · retrieved 2026-09-25T17:45:50.095Z
europe-pmc · retrieved 2026-09-25T17:45:50.140Z